Journament

Keyword Connections - itraconazole Keywords

Connection Type	Connection
Journals	Scientific reports European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology Viruses Open forum infectious diseases emerging microbes & infections Antiviral research Applied optics
Research Groups	No Research Group Connected
Bibliographies	[1] The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo. [2] Lipid Exchange Factors at Membrane Contact Sites in African Swine Fever Virus Infection. [3] Posaconazole inhibits dengue virus replication by targeting oxysterol-binding protein. [4] Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP). [5] Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts' consensus recommendations. [6] heat shock protein 90 (hsp90) as a molecular target for the development of novel drugs against the dermatophyte trichophyton rubrum [7] invasive pulmonary aspergillosis caused by aspergillus versicolor in a patient on mechanical ventilation [8] effect of itraconazole on the cornea in a murine suture model and penetrating keratoplasty model [9] investigations of seborrheic dermatitis. part ii. influenceof itraconazole on the clinical condition and the level of selected cytokinesin seborrheic dermatitis [10] primary mucocutaneous histoplasmosis presents as oral ulcer [11] intracranial regression of an advanced basal cell carcinoma using sonidegib and itraconazole after failure with vismodegib [12] heat shock protein 90 and calcineurin pathway inhibitors enhance the efficacy of triazoles against scedosporium prolificans via induction of apoptosis [13] Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST) [14] MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses-A Multicenter, Open-Label, Randomized Comparative Trial. [15] Comparable safety and non-inferior immunogenicity of the SARS-CoV-2 mRNA vaccine candidate PTX-COVID19-B and BNT162b2 in a phase 2 randomized, observer-blinded study. [16] Geometric lightguide for near-eye light field displays. [17] Parameters that determine dissolution and efficacy of itraconazole and its relevance to recalcitrant dermatophytoses. [18] Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis [19] Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis [20] The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo. [21] Antiviral activity of itraconazole against type I feline coronavirus infection. [22] Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP). [23] Antifungal azoles itraconazole and posaconazole exhibit potent in vitro antiviral activity against clinical isolates of parechovirus A3 (Picornaviridae). [24] Lubricant-Induced Crystallization of Itraconazole From Tablets Made of Electrospun Amorphous Solid Dispersion. [25] effect of itraconazole on the cornea in a murine suture model and penetrating keratoplasty model [26] comparing the effects of alcoholic extract of ginseng with itraconazole against candida albicans and candida krusei [27] investigations of seborrheic dermatitis. part ii. influenceof itraconazole on the clinical condition and the level of selected cytokinesin seborrheic dermatitis [28] intracranial regression of an advanced basal cell carcinoma using sonidegib and itraconazole after failure with vismodegib [29] itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs [corrigendum] [30] Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards [31] MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses-A Multicenter, Open-Label, Randomized Comparative Trial.